Recombinant Methanococcus maripaludis UPF0333 protein MMP0528 (MMP0528)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we are happy to accommodate specific format requests. Please indicate your preference when placing the order, and we will do our best to meet your requirements.
Lead Time
Delivery time may vary depending on the purchase method and location. Please consult your local distributors for precise delivery timelines.
Note: All of our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as an additional fee will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging this vial before opening to ensure the contents are settled at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting the solution at -20°C/-80°C. Our standard final glycerol concentration is 50%, which can serve as a reference for your needs.
Shelf Life
The shelf life is influenced by various factors, including storage conditions, buffer ingredients, storage temperature, and the inherent stability of the protein.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. For lyophilized form, the shelf life is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. For multiple uses, aliquoting is recommended to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during the production process. Should you require a specific tag type, please inform us, and we will prioritize developing the specified tag.
Synonyms
MMP0528; UPF0333 protein MMP0528
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-73
Protein Length
full length protein
Species
Methanococcus maripaludis (strain S2 / LL)
Target Names
MMP0528
Target Protein Sequence
MLKKLYSKKGQVSMEMGILVASAVAVAAIASYFYAVNVKYSDTHAGETAKNTSNALINVT ENVCGNISEITIP
Uniprot No.

Target Background

Database Links

KEGG: mmp:MMP0528

STRING: 267377.MMP0528

Protein Families
UPF0333 family
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is Methanococcus maripaludis UPF0333 protein MMP0528?

Methanococcus maripaludis UPF0333 protein MMP0528 is a 73-amino acid protein encoded by the MMP0528 gene in the archaeon Methanococcus maripaludis. This protein belongs to the UPF0333 family, whose specific function remains under investigation. The protein is typically produced as a recombinant protein with an N-terminal His-tag expressed in E. coli for research purposes . M. maripaludis is a methanogenic archaeon found primarily in marine environments, particularly salt marshes. It is a non-pathogenic, gram-negative, weakly motile, and strictly anaerobic mesophile with a pleomorphic coccoid-rod shape averaging 1.2 by 1.6 μm in size .

What is the amino acid sequence of MMP0528?

The complete amino acid sequence of Methanococcus maripaludis UPF0333 protein MMP0528 is:

MLKKLYSKKGQVSMEMGILVASAVAVAAIASYFYAVNVKYSDTHAGETAKNTSNALINVTENVCGNISEITIP

This 73-amino acid sequence represents the full-length protein. When expressed as a recombinant protein, it typically includes an N-terminal histidine tag to facilitate purification and identification. The protein has a UniProt ID of Q6LZU5 .

How is Methanococcus maripaludis classified taxonomically?

Methanococcus maripaludis is classified within the domain Archaea, which distinguishes it from bacteria and eukaryotes. Its complete taxonomic classification is as follows:

Taxonomic LevelClassification
DomainArchaea
KingdomMethanobacteriati
PhylumMethanobacteriota
ClassMethanococcia
OrderMethanococcales
FamilyMethanococcaceae
GenusMethanococcus
SpeciesM. maripaludis

The organism was first described by Jones et al. in 1984 and has since become an important model organism for studying archaeal biology and methanogenesis .

How does the metabolism of Methanococcus maripaludis relate to MMP0528 protein function?

While the specific function of MMP0528 protein has not been definitively characterized, understanding the metabolic context of M. maripaludis is crucial for hypothesis development regarding its role. M. maripaludis utilizes a modified Embden Meyerhof-Parnas (EMP) pathway that differs from typical glycolysis in several key aspects. Unlike other organisms that reduce NAD to NADH in the EMP pathway, M. maripaludis reduces ferredoxins. Additionally, its protein kinases uniquely rely on ADP rather than ATP for phosphate transfer .

The organism is capable of synthesizing glycogen and exhibits enzymatic activities in both catabolic and anabolic directions of the EMP pathway, with the anabolic direction predominating. This results in glycogen formation rather than breakdown . Given this unique metabolic profile, MMP0528 may potentially function in one of several metabolic capacities:

  • Membrane transport related to substrate acquisition

  • Signal transduction in metabolic regulation

  • Stress response related to maintaining metabolic homeostasis

Research examining protein-protein interactions between MMP0528 and enzymes in these pathways would be valuable for elucidating its function.

What approaches should be used to investigate the function of UPF0333 protein family members like MMP0528?

Investigating the function of uncharacterized proteins like MMP0528 requires a multi-faceted approach:

  • Structural analysis: Determine the three-dimensional structure through X-ray crystallography, NMR, or cryo-EM to identify potential functional domains or binding sites.

  • Comparative genomics: Analyze the conservation and genomic context of MMP0528 across related archaeal species to identify potential functional associations.

  • Gene knockout and phenotypic screening: Generate MMP0528 knockout strains and assess phenotypic changes in various growth conditions, particularly examining:

    • Growth rate under standard conditions

    • Methanogenesis efficiency

    • Response to environmental stressors

    • Changes in membrane integrity

  • Protein-protein interaction studies: Use pull-down assays, co-immunoprecipitation, or yeast two-hybrid screening to identify interaction partners.

  • Transcriptomic and proteomic profiling: Compare expression patterns between wild-type and knockout strains to identify pathways affected by MMP0528 absence.

Each experimental approach should include appropriate controls and statistical analysis methods, incorporating a minimum sample size of n=5 independent samples per experimental group to ensure statistical reliability .

What is the optimal protocol for reconstitution and storage of recombinant MMP0528 protein?

For optimal reconstitution and storage of recombinant MMP0528 protein:

  • Reconstitution procedure:

    • Briefly centrifuge the vial containing lyophilized protein before opening

    • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

    • Add glycerol to a final concentration of 50% (acceptable range: 5-50%)

    • Aliquot the reconstituted protein to minimize freeze-thaw cycles

  • Storage conditions:

    • Store lyophilized powder at -20°C/-80°C upon receipt

    • Store reconstituted aliquots at -20°C/-80°C for long-term storage

    • Working aliquots can be stored at 4°C for up to one week

    • Avoid repeated freeze-thaw cycles as they significantly reduce protein activity

  • Buffer considerations:

    • The protein is typically supplied in a Tris/PBS-based buffer with 6% Trehalose at pH 8.0

    • This formulation maintains protein stability while allowing flexibility for downstream applications

The reconstitution protocol should be validated for each experimental application by assessing protein activity and stability over time using appropriate functional assays.

How should power analysis be conducted for experiments involving MMP0528?

  • Essential parameters for power analysis:

    • Alpha (α): Typically set at 0.05 for biological research

    • Power (1-β): Generally aimed at 0.8 (80%) or higher

    • Effect size: Determined based on pilot studies or published literature

  • Implementation steps:

    • Conduct preliminary experiments to estimate effect size if no prior data exists

    • Use statistical software (G*Power, R, or other statistical packages) to calculate required sample size

    • Document all parameters and calculations in your methods section

    • Ensure a minimum of n=5 independent samples per group regardless of power analysis results

  • Example power analysis for MMP0528 protein-protein interaction experiment:

ParameterValueJustification
Test familyt-testsComparing means between experimental and control groups
Statistical testTwo-tailed independent t-testExamining both positive and negative effects
Alpha0.05Standard significance level
Power0.880% probability of detecting a true effect
Effect size (Cohen's d)1.5Based on preliminary data
Required sample size8 per groupCalculated minimum for statistical validity

Even when power analysis suggests smaller sample sizes are sufficient, adhering to the minimum of n=5 independent samples per group ensures more reliable p-values and reduces the risk of false positives or negatives .

What randomization and blinding procedures should be implemented in MMP0528 research?

Implementing proper randomization and blinding procedures is crucial for minimizing bias in MMP0528 research:

  • Randomization procedures:

    • Employ randomized block design to distribute samples across experimental conditions

    • Use computational random number generators rather than arbitrary assignment

    • Randomize at the level of the experimental subject (e.g., culture preparation, protein batch)

    • Document the specific randomization method in your methods section

  • Blinding implementation:

    • Code samples so that investigators are unaware of treatment groups during:
      a. Sample processing
      b. Data collection
      c. Initial data analysis

    • Use a separate investigator to prepare treatments and another to conduct analyses

    • Maintain blinding until after preliminary statistical analyses

    • Document all blinding procedures in the methods section

  • Experimental workflow with randomization and blinding:

StageProcedureImplementation
PreparationSample codingAssign random alphanumeric codes to samples
AllocationGroup assignmentUse randomized block design
TreatmentIntervention applicationApply treatments according to coded assignments
Data collectionMeasurementRecord outcomes without knowledge of group assignment
AnalysisInitial processingAnalyze raw data before revealing group identities
InterpretationFinal analysisReveal group identities only after preliminary statistics

These procedures are essential for ensuring experimental rigor and should be explicitly reported in publications to facilitate reproducibility and demonstrate methodological soundness .

How should contradictory results in MMP0528 functional studies be addressed?

When encountering contradictory results in MMP0528 functional studies, a systematic approach is necessary to resolve discrepancies:

When reporting contradictory results, explicitly acknowledge discrepancies, present all evidence transparently, and avoid confirmation bias by giving equal weight to all data regardless of expected outcomes.

What statistical approaches are most appropriate for analyzing MMP0528 protein interaction data?

When analyzing MMP0528 protein interaction data, selecting appropriate statistical approaches is essential for valid interpretation:

  • For qualitative interaction data (e.g., yeast two-hybrid screens):

    • Apply Fisher's exact test or chi-square test to assess significance of interactions

    • Implement multiple testing correction (Bonferroni or False Discovery Rate)

    • Report both raw p-values and adjusted p-values

    • Set significance threshold (p < 0.05) before conducting experiments

  • For quantitative binding data (e.g., surface plasmon resonance):

    • Fit binding curves using appropriate models (one-site binding, competitive binding)

    • Calculate dissociation constants (Kd) with 95% confidence intervals

    • Compare binding parameters using ANOVA or t-tests with minimum n=5 replicates

    • Avoid interpreting small differences in p-values as indicating different magnitudes of effect

  • For high-throughput interaction screening:

    • Implement normalization procedures appropriate to the platform

    • Use both positive and negative controls to establish detection thresholds

    • Apply statistical cut-offs consistently across all potential interactions

    • Validate high-confidence interactions using orthogonal methods

Analysis TypeStatistical ApproachRequirementsExample Application
Binary interactionFisher's exact testExpected values ≥5Comparing MMP0528 interactions under different conditions
Quantitative bindingNon-linear regressionAdequate sampling across concentration rangeDetermining MMP0528 binding affinity for potential partners
Multiple comparisonsANOVA with post-hoc testsNormal distribution, equal variancesComparing MMP0528 binding to multiple protein targets
Time-course dataRepeated measures ANOVAComplete time series, sphericityAnalyzing dynamic interaction patterns over time

Regardless of the specific approach, all statistical analyses should be decided before experimentation, described fully in the methods section, and implemented consistently .

How might MMP0528 research relate to methanogenesis pathways in Methanococcus maripaludis?

The study of MMP0528 in relation to methanogenesis pathways presents intriguing research opportunities:

  • Potential roles in methanogenesis:

    • MMP0528 may function in one of the seven hydrogenases present in M. maripaludis that enable the use of H₂ as an electron donor for CO₂ reduction

    • It could be involved in the Wolfe cycle, which converts CO₂ and hydrogen gas into methane and water

    • The protein might participate in the membrane-associated steps of methanogenesis, particularly given its sequence characteristics

  • Experimental approaches to investigate methanogenesis connection:

    • Generate MMP0528 knockout strains and measure methane production rates

    • Perform proteomic analysis of methanogenesis enzyme complexes to detect MMP0528

    • Use immunolocalization to determine if MMP0528 colocalizes with methanogenesis machinery

    • Conduct transcriptional analysis to determine if MMP0528 expression correlates with methanogenesis genes

  • Specific methanogenesis processes to examine:

    • Reduction of CO₂ via methanofuran and reduced ferredoxins

    • Oxidation and subsequent reduction of coenzyme F420

    • Transfer of methyl groups from methyl-THMPT to coenzyme M (HS-CoM)

    • Membrane processes involving Na⁺ translocation and proton gradient formation

Understanding MMP0528's potential role in these processes could provide insights into archaeal energy metabolism and potentially inform broader questions in evolutionary biochemistry.

What are the implications of MMP0528 research for understanding archaeal membrane proteins?

Research on MMP0528 has several important implications for understanding archaeal membrane proteins:

  • Structural insights:

    • The amino acid sequence of MMP0528 suggests potential membrane association, with hydrophobic regions (GILVASAVAVAAIASYFYAVN) characteristic of membrane proteins

    • Comparative analysis with other archaeal membrane proteins could reveal conserved structural features unique to Archaea

    • Understanding MMP0528 structure may illuminate adaptations that allow function in extreme environments

  • Evolutionary considerations:

    • As a member of the UPF0333 family, MMP0528 represents proteins of unknown function that may have evolved unique roles in Archaea

    • Comparative analysis across archaeal species could reveal evolutionary patterns and functional divergence

    • The protein may represent archaeal-specific adaptations that distinguish them from bacterial and eukaryotic membrane proteins

  • Methodological advancements:

    • Techniques optimized for MMP0528 study (expression, purification, reconstitution) may be applicable to other challenging archaeal membrane proteins

    • Development of archaeal-specific membrane protein analysis tools would benefit the broader field

    • Establishing protocols that maintain native conformations of archaeal membrane proteins would advance structural biology

  • Biotechnological applications:

    • Understanding archaeal membrane proteins like MMP0528 may inform the design of enzymes stable in extreme conditions

    • Knowledge gained could contribute to developing biological methane production systems for renewable energy

    • Insights may lead to novel applications in biotechnology that leverage the unique properties of archaeal proteins

Research on MMP0528 thus serves as a model for investigating the broader class of archaeal membrane proteins and their distinct evolutionary and functional characteristics.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.